GLP-1 receptor agonists and atherosclerosis protection: the vascular endothelium takes center stage.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- GLP-1 receptor agonists and atherosclerosis protection: the vascular endothelium takes center stage.
- Published In:
- American journal of physiology. Heart and circulatory physiology, 326(5), H1159-H1176 (2024)
- Authors:
- Park, Brady, Bakbak, Ehab, Teoh, Hwee, Krishnaraj, Aishwarya, Dennis, Fallon, Quan, Adrian, Rotstein, Ori D, Butler, Javed, Hess, David A, Verma, Subodh
- Database ID:
- RPEP-09037
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-09037APA
Park, Brady; Bakbak, Ehab; Teoh, Hwee; Krishnaraj, Aishwarya; Dennis, Fallon; Quan, Adrian; Rotstein, Ori D; Butler, Javed; Hess, David A; Verma, Subodh. (2024). GLP-1 receptor agonists and atherosclerosis protection: the vascular endothelium takes center stage.. American journal of physiology. Heart and circulatory physiology, 326(5), H1159-H1176. https://doi.org/10.1152/ajpheart.00574.2023
MLA
Park, Brady, et al. "GLP-1 receptor agonists and atherosclerosis protection: the vascular endothelium takes center stage.." American journal of physiology. Heart and circulatory physiology, 2024. https://doi.org/10.1152/ajpheart.00574.2023
RethinkPeptides
RethinkPeptides Research Database. "GLP-1 receptor agonists and atherosclerosis protection: the ..." RPEP-09037. Retrieved from https://rethinkpeptides.com/research/park-2024-glp1-receptor-agonists-and
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.